MedTrace Logo

Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management

NCT02992782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-13

No results posted yet for this study

Summary

Women who have undergone breast cancer surgery may develop swelling of the arm on the side the breast cancer occurred. If the swelling becomes chronic it is called lymphedema. This study will examine the effect of a 12-week decongestive progressive resistance exercise with advanced compression on breast cancer related lymphedema. Our objective is to determine if breast cancer survivors are willing and able to wear advanced compression while exercising and if the combination will help to reduce their lymphedema. Twenty-four breast cancer survivors from Edmonton, Alberta will be enrolled in the one-year long study.

Conditions

  • Breast Neoplasm
  • Lymphedema

Interventions

BEHAVIORAL

Standard Care

Home program of decongestive exercise and daily use of a compression sleeve

BEHAVIORAL

Exercise and Compression Garment

Decongestive progressive resistance exercise using flat-knit garment and daily use of a compression sleeve

BEHAVIORAL

Exercise and Adjustable Compression Wrap

Decongestive progressive resistance exercise using adjustable compression wrap and daily use of a compression sleeve

Sponsors & Collaborators

  • Cross Cancer Institute

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Margaret L McNeely, PhD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2023-08-14
Completion
2025-08-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02992782 on ClinicalTrials.gov